GHK-Cu
GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma and other tissues. Research has focused on its role in cellular signaling, extracellular-matrix biology, skin remodeling, and tissue-repair pathways.
What Is GHK-Cu?
GHK-Cu is a complex formed when the tripeptide glycyl-L-histidyl-L-lysine binds copper. The peptide occurs naturally in the body and has attracted research interest because copper is involved in numerous enzymatic and connective-tissue processes.
Laboratory and clinical research has explored GHK-Cu in areas including skin remodeling, collagen-related pathways, wound biology, inflammation, and cellular signaling.
The strength of evidence varies significantly by formulation and route of administration. Research involving topical copper-peptide products should not automatically be used to support claims about injectable GHK-Cu.
Mechanisms Being Studied
- Binds and transports copper ions
- Influences extracellular-matrix and collagen-related pathways
- Has been studied in cellular migration and tissue-remodeling biology
- May influence inflammatory and oxidative-stress signaling
- Has been investigated in skin and wound-repair research
What Does the Research Show?
GHK-Cu has a substantial laboratory research history, particularly in skin and tissue-remodeling biology. Human research has also evaluated certain topical copper-peptide preparations for cosmetic and dermatologic uses.
Much of the mechanistic literature involves cell culture, animal models, or topical formulations. Those findings are scientifically relevant but do not establish the safety or effectiveness of injectable GHK-Cu.
FDA has specifically noted limited human data for injectable GHK-Cu and has identified potential concerns related to immunogenicity, peptide aggregation, and peptide-related impurities.
Why Patients Ask About GHK-Cu
Goals commonly discussed include:
- Skin-quality and appearance goals
- Hair and scalp-related concerns
- Tissue-recovery and remodeling interests
- Healthy-aging and cosmetic wellness goals
- Interest in copper-peptide research
These are discussion areas, not approved indications or guaranteed treatment outcomes.
What to Know
Injectable GHK-Cu is not an FDA-approved drug. FDA has stated that human safety data for injectable GHK-Cu are limited and has identified potential concerns involving immunogenicity and peptide-related impurities.
FDA's 503A compounding status for GHK-Cu has also been under active review. The agency has announced plans for further advisory-committee consideration of GHK-Cu.
A provider should review your health history, medications, goals, route of administration, formulation, and alternative options before any therapy is considered.
Interested in GHK-Cu?
Schedule a consultation to discuss your goals, current health, and available treatment options.